Practice Guidelines for Chronic Kidney Disease
Authors: Carl Erik Mogensen
Journal: Annals of Internal Medicine (2004)

Letters1 June 2004Practice Guidelines for Chronic Kidney DiseaseCarl Erik Mogensen, MDCarl Erik Mogensen, MDFrom Aarhus University Hospital, DK-8000 Aarhus, Denmark.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-140-11-200406010-00024 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Screening for microalbuminuria is clearly recommended, especially for diabetes, by the American Diabetes Association, the new guidelines from the Seventh Joint National Commission on Health Care, and the European Society of Hypertension (1). Levey and colleagues (2) reported the National Kidney Foundation guidelines for chronic kidney disease. The problem with these guidelines regarding microalbuminuria is the initial step where an albumin-specific stick is proposed; this may be ill-defined. We propose the following, which is very much in line with the guidelines from the European Society of Hypertension and from the American Diabetes Association (Figure). Clinicians should start ...References1. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-53. [PMID: 12777938] CrossrefMedlineGoogle Scholar2. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al . National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-47. [PMID: 12859163] LinkGoogle Scholar3. Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med. 2003;254:45-66. [PMID: 12823642] CrossrefMedlineGoogle Scholar4. Yuyun MF, Dinneen SF, Edwards OM, Wood E, Wareham NJ. Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy. Diabet Med. 2003;20:277-82. [PMID: 12675640] CrossrefMedlineGoogle Scholar5. Spoelstra-de Man AM, Brouwer CB, Stehouwer CD, Smulders YM. Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria. Diabetes Care. 2001;24:2097-101. [PMID: 11723090] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Aarhus University Hospital, DK-8000 Aarhus, Denmark. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoNational Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification Andrew S. Levey , Josef Coresh , Ethan Balk , Annamaria T. Kausz , Adeera Levin , Michael W. Steffes , Ronald J. Hogg , Ronald D. Perrone , Joseph Lau , and Garabed Eknoyan Practice Guidelines for Chronic Kidney Disease Anthony Korosi Practice Guidelines for Chronic Kidney Disease Andrew S. Levey and Metrics Cited ByAssociation and biomarker potential of elevated serum adiponectin with nephropathy among type 1 and type 2 diabetics: A meta-analysisTriad of Metabolic Syndrome, Chronic Kidney Disease, and Coronary Heart Disease With a Focus on MicroalbuminuriaIncreased plasma adiponectin closely associates with vascular endothelial dysfunction in type 2 diabetic patients with diabetic nephropathy 1 June 2004Volume 140, Issue 11Page: 933-934KeywordsBlood pressureChronic kidney diseaseHypertensionLongitudinal studiesMicroalbuminuriaRenal diseasesType 2 diabetesUrinary tract infectionsUrine ePublished: 1 June 2004 Issue Published: 1 June 2004 CopyrightCopyright © 2004 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...